The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection

Gastroenterology

Volumn 134, Issue 5, 2008, Pages 1470-1481

  Zerbini, Alessandro ^a   Pilli, Massimo ^a   Boni, Carolina ^a   Fisicaro, Paola ^a   Penna, Amalia ^a   Di Vincenzo, Paola ^a   Giuberti, Tiziana ^a   Orlandini, Alessandra ^a   Raffa, Giuseppina ^b   Pollicino, Teresa ^b   Raimondo, Giovanni ^b   Ferrari, Carlo ^a   Missale, Gabriele ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS REPLICATION;

EID: 42949176196     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.017     Document Type: Article

References (27)

1. F. Zoulim New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA J Hepatol 42 2005 302 308
2. A. Penna M. Artini A. Cavalli Long-lasting memory T-cell responses following self-limited acute hepatitis B J Clin Invest 98 1996 1185 1194
3. B. Rehermann C. Ferrari C. Pasquinelli The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat Med 2 1996 1104 1108
4. F.V. Chisari C. Ferrari Hepatitis B virus immunopathology Springer Semin Immunopathol 17 1995 261 281
5. L.G. Guidotti T. Ishikawa M.V. Hobbs Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 1996 25 36
6. H. McClary R. Koch F.V. Chisari Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines J Virol 74 2000 2255 2264
7. M. Torbenson D.L. Thomas Occult hepatitis B Lancet Infect Dis 2 2002 479 486
8. T. Pollicino G. Raffa L. Costantino Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma Hepatology 45 2007 277 285
9. I. Cacciola T. Pollicino G. Squadrito Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease N Engl J Med 341 1999 22 26
10. N. De Maria A. Colantoni L. Friedlander The impact of previous HBV infection on the course of chronic hepatitis C Am J Gastroenterol 95 2000 3529 3536
11. T. Pollicino G. Squadrito G. Cerenzia Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 102 110
12. S. Momosaki Y. Nakashima M. Kojiro HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma J Viral Hepat 12 2005 325 329
13. S. Mrani I. Chemin K. Menouar Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C J Med Virol 79 2007 1075 1081
14. R. Fukuda N. Ishimura M. Niigaki Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance J Med Virol 58 1999 201 207
15. E. Sagnelli N. Coppola C. Scolastico Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment J Med Virol 65 2001 681 687
16. P. Fabris D. Brown G. Tositti Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C J Clin Virol 29 2004 160 166
17. E. Khattab I. Chemin I. Vuillermoz Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy J Clin Virol 33 2005 150 157
18. E.J. Wherry R. Ahmed Memory CD8 T-cell differentiation during viral infection J Virol 78 2004 5535 5545
19. F. Galibert E. Mandart F. Fitoussi Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli Nature 281 1979 646 650
20. C. Soderberg-Naucler J.Y. Nelson Human cytomegalovirus latency and reactivation—a delicate balance between the virus and its host's immune system Intervirology 42 1999 314 321
21. A.S. Fauci R.C. Desrosiers Pathogenesis of HIV and SIV J.M. Coffin S.H. Hughes H.E. Varmus Retroviruses 1997 Cold Spring Harbor Laboratory Press Plainview, NY
22. T.I. Michalak P.M. Mulrooney C.S. Coffin Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver J Virol 78 2004 1730 1738
23. V. Thiers E. Nakajima D. Kremsdorf Transmission of hepatitis B from hepatitis-B-seronegative subjects Lancet 2 1988 1273 1276
24. C.G. Schuttler N. Fiedler K. Schmidt Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein J Hepatol 37 2002 855 862
25. S.Y. Chen C.F. Kao C.M. Chen Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein J Biol Chem 278 2003 591 607
26. C.M. Shih S.J. Lo T. Miyamura Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells J Virol 67 1993 5823 5832
27. P. Valenzuela M. Quiroga J. Zalvidar The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes B.N. Fields R. Jaenisch C.F. Fox Animal virus genetics 1980 Academic Press New York 57 70